Spreading is a critical process involved in motility and growth of tumor cells during the metastatic cascade. Focal adhesion kinase, src-proteins and PKC have been reported to participate in the regulation of cytoskeleton organization in both normal and transformed cells during spreading. The role of other signaling enzymes such as PLD and PAP has not been studied during spreading in tumor cells. We now show that the spreading of murine mammary adenocarcinoma LM3 cells was significantly reduced by n-butanol, a PLD and PKC inhibitor, with a maximal inhibition of 54% (p F 0.001) in both the presence and absence of serum, as measured by phasecontrast microscopy. PMA only stimulated cell spreading over the control in the absence of serum and n-butanol inhibition was completely reversed by PMA treatment in both conditions. PA, the product of PLD activity, stimulated LM3 cell spreading and the same effect was observed with staurosporine. Spreading was enhanced when cells were seeded on collagen-IV-or fibronectin-coated surfaces and n-butanol could inhibit both integrin-derived signals. Focal adhesion and spreading are critical processes for morphology, anchorage, motility and growth of tumor cells (Hao Lo and Bo Chen, 1994). The interaction of tumor cells with components of the extracellular matrix (ECM) such as fibronectin (FN), collagen (CL) or laminin has been described as a key mechanism in metastasis formation (Juliano, 1994;Brodt, 1996). Within the final steps of the metastatic cascade, tumor cells, after binding to the endothelium of the target organ, have to adhere, spread and migrate on specific components of the ECM and basement membrane, in order to extravasate and develop metastatic foci (Brodt, 1996). However, it is not clear which are the effector molecules and signaling pathways regulating tumor-cell adhesion and spreading required for motility during different stages of the metastatic cascade.